Clinical trial
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
NCT00152217 · Taiho Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00152217 |
|---|---|
| Title | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) |
| Official title | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) |
| Lead sponsor | Taiho Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Procedure |
| Interventions | TS-1 (S-1), Surgery |
| Enrollment | 1,000 |
| Start date | Sep 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | Dec 1, 2010 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 7, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: